Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
Rockwell Collins Wins $289M Integrated Radio Equipment Deal

1h zacks
Rockwell Collins, Inc.’s (COL - Free Report) Government Systems business division recently won a $288.5-million modification contract for the manufacture and delivery of the AN/ARC-210 radio equipment systems. The deal will cater to the U.S. Navy, Air Force, Marine Corps and Foreign Military Sales customers. The contract was awarded by the Naval Air Warfare Center Aircraft Division, Patuxent River, MD.
AJRD HII MLNX EGL UTX COL

5
Pershing Square Holdings Ltd. (PSHZF) CEO Bill Ackman on Q2 2018 Results - Earnings Call Transcript

2018-08-15 seekingalpha
Pershing Square Holdings Ltd. (OTCPK:PSHZF) Q2 2018 Earnings Conference Call August 15, 2018 11:00 AM ET
HD THI PSHZF UTX COL HHC MS

1
United Technologies (UTX) Prices $11B Senior Notes Offering

2018-08-14 zacks
United Technologies Corporation (UTX - Free Report) , yesterday, has priced an offering of $11-billion senior notes, which are to be issued under a self registration statement. This statement has been filed with the Security and Exchange Commission. Subject to customary closing conditions, this offering is anticipated to close on Aug 16, 2018. The offering has been made in different trances, including $1 billion of 3.
FSS CSL UTX CR COL

1
Aerospace & Defense ETF As A Way To Profit From Two Attractive Industries

2018-08-13 seekingalpha
Both the aerospace as well as the defense industry are attractive for investors. Companies from both industries have created a lot of value for shareholders in the past, and both will benefit from long-term growth trends over the coming decades.
LMT NOC GD HXL HXL UTX COL ITA

2
The Top 7 Aviation and Aerospace Stocks to Buy Now

2018-08-11 investorplace - 1
On the one hand, they’ve enjoyed an amazing run in recent years. On the commercial side of the business, order activity has soared. Airlines have gone on a spending spree. Thanks to plunging jet fuel prices, airlines have earned unusually large profits and are taking advantage of the windfall to modernize their fleets. That said, with the oil market on the mend, commercial airlines are likely to see profits start to revert toward normal.
LMT CAAP UTX AYR COL BA ASR ERJ

5
Pershing Q2 New Positions In UTX And Lowe's; On Fannie Mae Expects A Decision "in the late spring or summer of 2019" - ValueWalk

2018-08-09 valuewalk
Get the entire 10-part series on our in-depth study on activist investing in PDF. Save it to your desktop, read it on your tablet, or print it out to read anywhere! Sign up below!
HHC HD THI UTX COL

1
SpeedNews Defense & Space

2018-08-09 aviationweek
ROCKWELL COLLINS has $90m U.S. Army foreign military sales for communications and electronic equipment and technical services for Saudi Arabia and Turkey. NORTHROP GRUMMAN has $29.9m U.S. Navy contract for procurement/delivery of 45 end items of Peculiar Support Equipment (PSE) for E-2D Advanced Hawkeye aircraft. LOCKHEED MARTIN has $15.8m U.S. Missile Defense Agency contract for materials and work supporting Aegis Ballistic Missile Defense (BMD) Increment 3 Capability .
LMT NOC COL

16
SpeedNews Defense & Space

2018-08-02 aviationweek
GENERAL ELECTRIC has $630.5m U.S. Navy contract for repair, replacement, program support of 773 F414 engine components used on F/A-18 E/F and EA-18G. LOCKHEED MARTIN has $171.7m U.S. Navy contract for diminishing manufacturing sources redesign activities for F-35 Lightning II. ROCKWELL COLLINS has $21m U.S. Navy contract for 140 Joint Helmet-Mounted Cueing system, Night Vision Cueing and Display systems for Navy/Marine Corps F/A-18s.
LMT NOC GEC GE GNE COL

2
Iridium Communications Inc (IRDM) CEO Matt Desch on Q2 2018 Results - Earnings Call Transcript

2018-07-31 seekingalpha - 1
Good morning and welcome to the Iridium Communications Second Quarter Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
IRDDA IRDMB COL IRDM IRIIZ

1
Rockwell Collins' Pro Line Fusion avionics and air data systems chosen for AVIC MA700 turboprop regional aircraft

2018-07-31 asdnews
Rockwell Collins has signed master contracts with AVIC Aircraft Co., Ltd (AVIC Aircraft), a subsidiary of Aviation Industry Corporation of China, Ltd. (AVIC), to supply its Pro Line Fusion® advanced avionics system and air data systems for MA700 turboprop regional aircraft. AVIC has also chosen Rockwell Collins’ HGS™-3500 Head-up Guidance System – an innovative, all-in-one compact head-up display (HUD) solution – as an airline-selectable option.
COL

1
Rockwell Collins reports increased Q3 sales

2018-07-30 janes
Rockwell Collins has reported a 5% increase in sales year on year for the third quarter of fiscal year 2018 (FY 2018), with an increase of 13% recorded for sales in its government division.
COL

1
Aerospace-Defense Equipment Outlook: Budget a Boon Amid Trade War

2018-07-27 zacks
The latest budget proposals from Pentagon, reflecting hawkish spending provisions for the U.S. Department of Defense (DoD), along with rapidly rising global air traffic boosting aircraft production rates should keep the U.S. Aerospace-Defense Equipment stocks’ momentum alive. However, increasing competition with nations like China that are vigorously engaged in unveiling their aerospace and defense equipment poses a threat for the near-term growth prospects of this space.
AJRD HEI.A HEI RTN UTX COL

1
Rockwell Collins (COL) Q3 Earnings Miss, Revenues Up Y/Y

2018-07-27 zacks
Rockwell Collins Inc. (COL - Free Report) reported financial results for third-quarter fiscal 2018 (ended Jun 30, 2018). The company’s adjusted earnings per share of $1.73 lagged the Zacks Consensus Estimate of $1.89 by 8.5%. Reported earnings, however, grew 5.5% from $1.64 per share a year ago. Excluding the one-time items, the company reported GAAP earnings per share of $1.66 in the reported quarter, which increased 48.
LMT HXL HXL GNC XL XLGLF COL TXT

2
Rockwell Collins (COL) Misses Q3 Earnings & Revenue Estimates

2018-07-27 zacks
Rockwell Collins Inc. (COL - Free Report) is the foremost global supplier of communications and avionics equipment for both commercial and military customers. It follows a strategic acquisition program. Apart from its acquisition- driven growth strategy, Rockwell Collins remains focused to expand its product and service offering through continuous investments in research and development activities.
TPH NVR UTX COL TRN

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 774341101